Welcome
Support Centre
30 July 2010 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The effect of patient education on compliance with drug therapy for rheumatoid arthritis
Source of recordUK Trials
ISRCTNISRCTN68585617
Date ISRCTN assigned30/07/2002
Local reference number(s)B0508
Public titleThe effect of patient education on compliance with drug therapy for rheumatoid arthritis
Scientific title
AcronymN/A
Disease/condition/study domainRheumatoid arthritis
Study hypothesisTreatment of rheumatoid arthritis (RA) by disease-modifying drugs in which dosage is not symptom driven, is subject to substantial variation in compliance. Our previous work, using a novel pharmacological 'gold standard' for the measurement of compliance in which D-penicillamine was labelled with a homeopathic dose of phenobarbitone, showed that 42% of patients failed to follow instructions of dosage. It is proposed to use the same objective technique, validated clinical measures and a proven knowledge questionnaire, to investigate the effect on compliance of two different levels of patient education amongst RA patients.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. All patients deemed by the consultant rheumatologist to require dPenicillamine (DPA) as their disease modifying anti-rheumatic drug (DMARD)
2. Over 18 years of age
3. Plasma Viscosity (PV) ≤1.75
4. Cysteine rich protein (CRP) ≤10
5. Articular index 15 or less than
6. Morning stiffness ≤45 min
7. Pain level moderate/severe
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date12/01/1993
Anticipated end date31/08/1998
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsExperimental group received a patient education programme
Primary outcome measure(s)It is anticipated that effective education will enhance compliance leading to better drug utilisation and improved patient outcome.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingArthritis Research Campaign
Sponsor nameArthritis Research Campaign (UK)
Sponsor detailsCopeman House
St Mary's Court
St Mary's Gate
Chesterfield
Derbyshire
United Kingdom
S41 7TD
Sponsor emailinfo@arc.org.uk
Sponsor websitehttp://www.arc.org.uk
Contact nameMs Jackie Hill
Contact detailsCPU (Rheumatism Research)
University of Leeds
Chapel Allerton Hospital
Harehills Lane
Leeds
United Kingdom
LS7 4SA
Contact telephone+44 (0)113 262 3404
Contact emailj.hill@leeds.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN68585617
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central